5GVC
Human Topoisomerase IIIb topo domain
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL41XU |
Synchrotron site | SPring-8 |
Beamline | BL41XU |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2014-05-22 |
Detector | DECTRIS PILATUS3 S 6M |
Wavelength(s) | 1.00 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 176.088, 93.665, 91.608 |
Unit cell angles | 90.00, 91.88, 90.00 |
Refinement procedure
Resolution | 49.718 - 2.436 |
R-factor | 0.1844 |
Rwork | 0.182 |
R-free | 0.22920 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4cgy |
RMSD bond length | 0.002 |
RMSD bond angle | 0.685 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | PHENIX (1.9_1692) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.480 |
High resolution limit [Å] | 2.440 | 2.440 |
Number of reflections | 55090 | |
<I/σ(I)> | 13.4 | |
Completeness [%] | 99.1 | |
Redundancy | 6.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 277 | 0.1 M HEPES-Na, 0.2 M MgCl2, 25% PEG3350 |